Return to search results
Interferon beta-1a
Rebif (interferon beta-1a) is a prescription medication manufactured by EMD Serono, Inc., used to treat relapsing forms of multiple sclerosis (MS). It comes in prefilled syringes for subcutaneous injection in strengths of 22 mcg/0.5 mL and 44 mcg/0.5 mL. Approved in 2002 under BLA103780, it belongs to the interferon beta class of drugs. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Rebif (interferon beta-1a) is a prescription medication manufactured by EMD Serono, Inc., used to treat relapsing forms of multiple sclerosis (MS). It comes in prefilled syringes for subcutaneous injection in strengths of 22 mcg/0.5 mL and 44 mcg/0.5 mL. Approved in 2002 under BLA103780, it belongs to the interferon beta class of drugs. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Interferon beta-1a",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Interferon beta-1a — ANDA 103628 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628"
}
]
|
| identifier | ANDA103628 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"fda",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Interferon beta-1a |
